Trade with Eva: Analytics in action >>
Showing posts with label SHW. Show all posts
Showing posts with label SHW. Show all posts

Thursday, January 26, 2017

=Sherwin-Williams (SHW) reported earnings on Thur 26 Jan 2017 (b/o)




Sherwin-Williams misses by $0.06, beats on revs :
  • Reports Q4 (Dec) earnings of $2.15 per share, excluding non-recurring items, $0.06 worse than the Capital IQ Consensus of $2.21; revenues rose 6.8% year/year to $2.78 bln vs the $2.68 bln Capital IQ Consensus.
  • Co issues guidance for Q1, sees EPS of $1.45-1.55, may not be comparable to $1.96 Capital IQ Consensus Estimate. First quarter 2017 earnings per share includes costs related to the anticipated acquisition of Valspar totaling approximately $.69 per share and an increase of approximately $.11 per share related to the decrease in the income tax provision.
    • Q1 anticipate consolidated net sales will increase a mid to high single digit percentage y/y.
  • Co issues guidance for FY17, sees EPS of $13.00-13.20, may not be comparable to $13.70 Capital IQ Consensus Estimate. Full year 2017 earnings per share includes costs related to the anticipated acquisition of Valspar totaling approximately $.80 per share and an increase of approximately $.20 per share related to the decrease in the income tax provision
    • For the full year 2017, expect consolidated net sales to increase a mid single digit percentage compared to full year 2016.
  • Valspar (VAL) Acquisition
    • "We now expect a divestiture will be required to gain approval from the FTC to complete the acquisition of Valspar. We are moving forward on a divestiture that we believe will allow us to gain approval from the FTC. The expected divestiture has revenues below the $650 million threshold, and we expect to negotiate the divestiture and complete the Valspar transaction at $113 per common share within 90 days".

Tuesday, October 25, 2016

=Sherwin-Williams (SHW) reported earnings on Tue 25 Oct 2016 (b/o)




Sherwin-Williams misses by $0.09, reports revs in-line; guides Q4 EPS below consensus; lowers FY16 EPS guidance; appoints Al Mistysyn CFO effective Jan 2017  :
  • Reports Q3 (Sep) earnings of $4.23 per share, excluding non-recurring items, $0.09 worse than the Capital IQ Consensus of $4.32; revenues rose 4.0% year/year to $3.28 bln vs the $3.28 bln Capital IQ Consensus.
  • Co issues downside guidance for Q4, sees EPS of $2.13-2.23, excluding costs related to the anticipated acquisition of Valspar totaling approximately $.71 per share and an increase in EPS of approximately $.03 per share related to the decrease in the income tax provision, vs. $2.43 Capital IQ Consensus Estimate. Core consolidated net sales expected to increase by a low single digit percentage compared to last year's fourth quarter.
  • Co lowers EPS guidance for FY16, sees EPS of $12.25-12.35 (prior $12.50-12.70), excluding costs related to the anticipated acquisition of Valspar totaling approximately $1.35 per share and an increase in EPS of approximately $.40 per share related to the decrease in the income tax provision, vs. $12.63 Capital IQ Consensus Estimate.
  • Mistysyn has served as Sherwin-Williams' Senior Vice President -- Corporate Controller since October 2014 and will assume the CFO duties currently held by Sean P. Hennessy. Mr. Hennessy will remain with the Company in the role of Senior Vice President -- Corporate Planning, Development and Administration where he will provide support for the Valspar acquisition integration planning process and assist Mr. Mistysyn with his new role to ensure a smooth transition of responsibilities.

Thursday, July 21, 2016

=Sherwin-Williams (SHW) reported earnings on Thur 21 Jul 2016 (b/o)





Sherwin-Williams misses by $0.10, misses on revs; guides Q3 EPS below consensus; reaffirms FY16 guidance  :
  • Reports Q2 (Jun) earnings of $4.06 per share, excluding non-recurring items, $0.10 worse than the Capital IQ Consensus of $4.16; revenues rose 2.8% year/year to $3.22 bln vs the $3.28 bln Capital IQ Consensus.
  • Co issues downside guidance for Q3, sees EPS of $4.20-4.40, excluding Valspar (VAL) acquisition costs & a tax benefit, vs. $4.41 Capital IQ Consensus Estimate.
    • Anticipates 3Q16 sales increase of low to mid single digit percentage
  • Co reaffirms guidance for FY16, sees EPS of $12.50-12.70, excluding Valspar (VAL) acquisition costs & a tax benefit, vs. $12.68 Capital IQ Consensus Estimate.
    • For the full year 2016 expects consolidated net sales to increase by a low single digit percentage compared to full year 2015

Thursday, January 28, 2016

=Sherwin-Williams (SHW) reported 4Q earnings on Thur 28 Jan 2016 (before open)

** charts before earnings **



** charts after earnings **






Sherwin-Williams beats by $0.25, reports revs in-line; guides Q1 EPS in-line; guides FY16 EPS below consensus :
  • Reports Q4 (Dec) earnings of $2.12 per share, $0.25 better than the Capital IQ Consensus of $1.87; revenues rose 1.4% year/year to $2.6 bln vs the $2.59 bln Capital IQ Consensus
  • Co continues to generate significant cash from operations allowing it to invest in the business and return a substantial portion to our shareholders
  • Co issues in-line guidance for Q1, sees EPS of $1.50-1.65 vs. $1.59 Capital IQ Consensus Estimate; co anticipates its consolidated net sales will increase a low single digit percentage compared to the first quarter of 2015 
  • Co issues downside guidance for FY16, sees EPS of $12.20-12.40 vs. $12.73 Capital IQ Consensus Estimate; co expects consolidated net sales to increase a low single digit percentage compared to full year 2015

Thursday, October 29, 2015

Sherwin-Williams (SHW) reported earnings Thur 29 Oct 2015 (before open)

** chart before earnings **





** charts after earnings **



10 days later.......